Royalty Pharma plc (RPRX)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Pablo Legorreta
|
Founder, Chairman of the Board & CEO | 44.02M | -- | 1963 |
|
Mr. Terrance P. Coyne
|
Executive VP & CFO | 1.32M | -- | -- |
|
Mr. Christopher Hite
|
Chairman of Partnering & Investments | 1.32M | -- | 1967 |
|
Dr. Marshall Jonathan Urist M.D., Ph.D.
|
Head of Research & Investments | 1.32M | -- | 1976 |
|
Mr. Greg Butz
|
Executive Vice President of Partnering & Investments | -- | -- | -- |
|
Mr. Eric Cornelius Schneider
|
Senior VP & Chief Technology Officer | -- | -- | -- |
|
Dr. James Folmar Reddoch Ph.D.
|
Executive VP of Investments & Chief Scientific Officer | 3.4M | -- | 1970 |
|
Mr. George Grofik C.F.A., CPA
|
Senior VP and Head of Investor Relations & Communications | -- | -- | -- |
|
Mr. Arthur Richard McGivern J.D.
|
Executive VP of Investment & Chief Legal Officer | -- | -- | 1975 |
|
Ms. Molly Sawaya
|
Executive VP & Head of Human Capital | -- | -- | -- |
Royalty Pharma plc
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 100
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.
Corporate Governance
Upcoming Events
November 4, 2026 at 12:30 PM UTC
Royalty Pharma plc Earnings Date
November 13, 2026 at 12:00 AM UTC
Ex-Dividend Date
December 10, 2026 at 12:00 AM UTC
Dividend Date
